Illumina And PREMIA Expand Genomic Profiling Access

Illumina Taiwan Biotechnology and Precision Medicine Asia (PREMIA) announced a strategic partnership with Chang Gung Memorial Hospital (CGMH) to expand comprehensive genomic profiling (CGP) for eligible oncology patients across the CGMH system and to build an Asia-wide clinical-genomic oncology database. The agreement aims to streamline testing workflows, support translational research and drug development, and follows CGP's incorporation into Taiwan's National Health Insurance in May 2024.